- Published at
- by zacks.com
positive
positive
Bruker Stock to Benefit From the Launch of X4 POSEIDON Benchtop XRM
BRKR unveils X4 POSEIDON advanced XRM for 3D microscopy in industrial and scientific applications.
News for Bruker Corporation (BRKR)
- Published at
- by insidermonkey.com
positivepositiveIs Bruker Corporation (BRKR) the Best Medical Technology Stock to Buy According to Analysts?
We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against...- Published at
- by gurufocus.com
positivepositiveBruker Launches X4 POSEIDON™ Advanced X-Ray Microscope for Three-Dimensional Microscopy in Industrial and Scientific Applications
[url="]Bruker Corporation[/url] (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDONâ„¢, a high-performance 3D X-ray microscope (XRM) using micro-C- Published at
- by insidermonkey.com
neutralneutralBruker Corporation (BRKR) is on Detractors’ list of The London Company SMID Cap Strategy
The London Company, an investment management company, released “The London Company SMID Cap Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. U.S.- Published at
- by gurufocus.com
positivepositiveBruker Advances Single-Cell Proteomics and Immunopeptidomics Performance; Unveils New Proteomics Software and Applications for Enhanced Biological Insights at US HUPO
At the [url="]21st Annual US HUPO Conference[/url], [url="]Bruker Corporation[/url] (Nasdaq: BRKR) announces significant advances in 4D-Proteomicsâ„¢ performan- Published at
- by seekingalpha.com
neutralneutralBruker declares $0.05 dividend (NASDAQ:BRKR)
Bruker (BRKR) announces $0.05/share quarterly dividend with a 0.38% yield. Key dates: ex-div March 17, payable March 28.- Published at
- by zacks.com
neutralneutralBruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls
Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024.- Published at
- by seekingalpha.com
positivepositiveBruker projects 11%-13% EPS growth and 140 bps margin expansion for 2025 amid strong semi and diagnostics performance (NASDAQ:BRKR)
Discover key takeaways from Bruker Corporation's Q4 2024 earnings call, highlighting strong diagnostics, semiconductor growth, and confident 2025 revenue...- Published at
- by seekingalpha.com
positivepositiveBruker Corporation (BRKR) Q4 2024 Earnings Call Transcript
Bruker Corporation (NASDAQ:BRKR) Q4 2024 Results Conference Call February 13, 2025 8:30 AM ETCompany ParticipantsJoe Kostka - Director, Investor...- Published at
- by zacks.com
neutralneutralBruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Bruker (BRKR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.- Published at
- by zacks.com
neutralneutralBruker (BRKR) Q4 Earnings and Revenues Surpass Estimates
Bruker (BRKR) delivered earnings and revenue surprises of 1.33% and 0.91%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by gurufocus.com
positivepositiveBruker Reports Fourth Quarter and Full Year 2024 Financial Results
[url="]Bruker Corporation[/url] (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2024. Frank- Published at
- by seekingalpha.com
neutralneutralBruker Non-GAAP EPS of $0.76 beats by $0.02, revenue of $979.6M beats by $13.99M (NASDAQ:BRKR)
Bruker reports Q4 revenue of $979.6M (+14.6% Y/Y) & beats estimates, with FY 2025 guidance projecting up to 7% CER revenue growth.- Published at
- by seekingalpha.com
neutralneutralBruker Q4 2024 Earnings Preview (NASDAQ:BRKR)
Bruker (BRKR) to report Q4 earnings on Feb 13. Consensus EPS: $0.74, Revenue: $965.61M.- Published at
- by gurufocus.com
positivepositiveBruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast
[url="]Bruker Corporation[/url] (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before market opening on Th- Published at
- by zacks.com
positivepositiveBruker (BRKR) to Report Q4 Results: Wall Street Expects Earnings Growth
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.- Published at
- by seekingalpha.com
positivepositiveBruker Pivots To Capitalize Its Growing TAM (NASDAQ:BRKR)
Financial writer recommends buying Bruker Corporation (BRKR) due to undervaluation, strategic acquisitions, and growth potential by FY2025.- Published at
- by investing.com
negativenegativeWaters, related stocks fall on new biotech export controls By Investing.com
Waters, related stocks fall on new biotech export controls- Published at
- by gurufocus.com
positivepositiveBruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
[url="]Bruker Corporation[/url] (Nasdaq: BRKR) announced today it will participate in the 43rd annual J.P. Morgan Healthcare Conference in San Francisco. Frank- Published at
- by insidermonkey.com
positivepositive12 Best Nanotechnology Stocks to Buy According to Hedge Funds
Nanotechnology, a groundbreaking concept introduced by Nobel Prize-winning physicist Richard Feynman in 1959 during a speech at Caltech, focuses on working with materials at an incredibly small scale—...